Starting treatment with a regimen containing doravirine and tenofovir disoproxil (TDF) resulted in less weight gain than starting treatment with a regimen containing dolutegravir and tenofovir alafenamide, a South African study reported yesterday week at the 26th International AIDS Conference in Rio de Janeiro, Brazil. Starting treatment with a regimen containing doravirine and tenofovir disoproxil (TDF) resulted in less weight gain than starting treatment with a regimen containing dolutegravir and tenofovir alafenamide, a South African study reported yesterday wee... [5004 chars]
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
